Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study
Open Access
- 1 January 2013
- journal article
- research article
- Published by Elsevier BV in Clinics
- Vol. 68 (10), 1338-1343
- https://doi.org/10.6061/clinics/2013(10)08
Abstract
OBJECTIVE: Accelerated bone loss that occurs in postmenopausal women has been linked to oxidative stress and increased free radicals. We propose the use of antioxidants to prevent and reverse postmenopausal osteoporosis. This study aimed to examine the effects of tocotrienol, a vitamin E analog, on bone loss due to estrogen deficiency. Our previous study showed that tocotrienol increased the trabecular bone volume and trabecular number in ovariectomized rats. In the current study, we investigated the effects of tocotrienol supplementation on various biochemical parameters in a postmenopausal osteoporosis rat model. MATERIALS AND METHODS: A total of 32 female Wistar rats were randomly divided into four groups. The baseline group was sacrificed at the start of the study, and another group was sham operated. The remaining rats were ovariectomized and either given olive oil as a vehicle or treated with tocotrienol at a dose of 60 mg/kg body weight. After four weeks of treatment, blood was withdrawn for the measurement of interleukin-1 (IL1) and interleukin-6 (IL6) (bone resorbing cytokines), serum osteocalcin (a bone formation marker) and pyridinoline (a bone resorption marker). RESULTS: Tocotrienol supplementation in ovariectomized rats significantly reduced the levels of osteocalcin, IL1 and IL6. However, it did not alter the serum pyridinoline level. CONCLUSION: Tocotrienol prevented osteoporotic bone loss by reducing the high bone turnover rate associated with estrogen deficiency. Therefore, tocotrienol has the potential to be used as an anti-osteoporotic agent in postmenopausal women.Keywords
This publication has 37 references indexed in Scilit:
- Palm Tocotrienol Supplementation Enhanced Bone Formation in Oestrogen-Deficient RatsInternational Journal of Endocrinology, 2012
- Two Different Isomers of Vitamin E Prevent Bone Loss in Postmenopausal Osteoporosis Rat ModelEvidence-Based Complementary and Alternative Medicine, 2012
- Physiology of Bone LossRadiologic Clinics of North America, 2010
- Vitamin E exhibits bone anabolic actions in normal male ratsJournal of Bone and Mineral Metabolism, 2009
- Palm Tocotrienol Exerted Better Antioxidant Activities in Bone than α-TocopherolBasic & Clinical Pharmacology & Toxicology, 2008
- Osteoporosis and InflammationNutrition Reviews, 2008
- TOCOTRIENOL OFFERS BETTER PROTECTION THAN TOCOPHEROL FROM FREE RADICAL‐INDUCED DAMAGE OF RAT BONEClinical and Experimental Pharmacology and Physiology, 2005
- Osteoclast-derived activity in the coupling of bone formation to resorptionTrends in Molecular Medicine, 2005
- Tocotrienols are needed for normal bone calcification in growing female ratsAsia Pacific Journal of Clinical Nutrition, 2002
- Stimulation of osteoclastic bone resorption by hydrogen peroxideBiochemical and Biophysical Research Communications, 1992